Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA Fact Sheet  (NTPH)



Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF


Here is the latest financial fact sheet of NATCO PHARMA. For more details, see the NATCO PHARMA quarterly results and NATCO PHARMA share price. For a sector overview, read our pharmaceuticals sector report.

NATCO PHARMA Price History

Price Rs 993.8
Mkt Cap Rs m 177,990
Vol '000 10.8
P/E X 13.9
P/CF X 20.2
EPS (TTM) Rs 71.3
1 Day % -0.1
No. of shares m 179.11
1 Week % 0.5
1 Month % 4.7
1 Year % 74.4
52 week H/L Rs 1,107.9/550.5
As on Apr 19, 2024 12:34:00 PM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

NATCO PHARMA Financials

No. of Mths
Year Ending
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
12
Mar-23
*
5-Yr Chart
Click to enlarge
NATCO PHARMA EQUITY SHARE DATA
High Rs8497389951,189847 
Low Rs557450492750502 
Sales per share (Unadj.) Rs114.6105.2112.5106.6148.4 
Earnings per share (Unadj.) Rs35.225.224.39.339.2 
Diluted earnings per shareRs35.925.624.79.539.9 
Cash flow per share (Unadj.) Rs39.630.630.717.148.2 
Dividends per share (Unadj.) Rs6.256.755.254.505.50 
Adj. dividends per shareRs6.386.865.344.595.60 
Avg Dividend yield %0.91.10.70.50.8 
Book value per share (Unadj.) Rs189.2206.0225.1233.4267.1 
Adj. book value per shareRs193.1209.4229.1237.9272.1 
Shares outstanding (eoy) m182.75182.07182.34182.52182.47 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x6.15.66.69.14.5 
Avg P/E ratio x20.023.630.6104.117.2 
P/CF ratio (eoy) x17.819.424.256.614.0 
Price / Book Value ratio x3.72.93.34.22.5 
Dividend payout %17.826.821.648.314.0 
Avg Mkt Cap Rs m128,471108,130135,564176,990123,049 
No. of employees `000NANANANANA 
Total wages/salary Rs m3,5593,7504,1494,4484,867 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
NATCO PHARMA INCOME DATA
Net Sales Rs m20,94519,15020,52119,44827,071 
Other income Rs m1,3021,0741,0609901,285 
Total revenues Rs m22,24720,22421,58120,43828,356 
Gross profit Rs m7,9485,8266,0382,6359,117 
Depreciation Rs m8109981,1691,4261,638 
Interest Rs m193215133177145 
Profit before tax Rs m8,2475,6875,7962,0228,619 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,8231,1061,3723221,466 
Profit after tax Rs m6,4244,5814,4241,7007,153 
Gross profit margin %37.930.429.413.533.7 
Effective tax rate %22.119.423.715.917.0 
Net profit margin %30.723.921.68.726.4 
NATCO PHARMA BALANCE SHEET DATA
Current assets Rs m23,47223,25623,44824,86730,003 
Current liabilities Rs m7,2876,8535,2567,1046,831 
Net working cap to sales %77.385.788.791.385.6 
Current ratio x3.23.44.53.54.4 
Inventory Days Days4236637263 
Debtors Days Days8810573116115 
Net fixed assets Rs m19,55922,62224,47126,22426,571 
Share capital Rs m365364365365365 
"Free" reserves Rs m34,21737,13640,67642,23748,373 
Net worth Rs m34,58237,50041,04142,60248,738 
Long term debt Rs m09000 
Total assets Rs m43,03145,87847,91951,09156,574 
Interest coverage x43.727.544.612.460.4 
Debt to equity ratio x00000 
Sales to assets ratio x0.50.40.40.40.5 
Return on assets %15.410.59.53.712.9 
Return on equity %18.612.210.84.014.7 
Return on capital %24.415.714.45.218.0 
Exports to sales %00000 
Imports to sales %14.09.510.920.010.2 
Exports (fob) Rs m00000 
Imports (cif) Rs m2,9391,8182,2313,8822,772 
Fx inflow Rs m11,5368,73611,1948,88117,256 
Fx outflow Rs m2,9391,8182,2313,8822,772 
Net fx Rs m8,5976,9188,9634,99914,484 
NATCO PHARMA CASH FLOW
From Operations Rs m 6,688 4,173 2,988 465 8,491 
From Investments Rs m -6,122 -1,670 -1,033 -53 -4,771 
From Financial Activity Rs m -509 -2,508 -1,857 348 -3,630 
Net Cashflow Rs m 66 -85 60 853 208 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 49.7%
Institution 25.8%
Non-Institution 24.5%
Total 100.0%
Free Float 50.3%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2024
 

Company Information

Regd Off Natco House, Road No 2, Banjara Hills, Hyderabad - 500034
E-mail investors@natcopharma.co.in / dasaradhi@natcopharma.co.in Web www.natcopharma.co.in
Tel 040-23547532 Fax 040-23548243
Sector PHARMACEUTICALS Group Natco
Tr Agent Venture Capital & Corporate Investments Ltd, Aurum Door No 4-50/P-II/57/4F&5F Plot No 57, 4th & 5th Floors, Jayabheri Enclave Phase - II Gachibowli
Auditor Walker, Chandiok & Co.
CHM: G S Murthy COMP SEC: Chekuri Venkat Ramesh YEAR OF INC: 1981 BSE CODE: 524816 FV (Rs): 2 DIV YIELD (%): 0.6

Read: NATCO PHARMA 2022-23 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    

Compare NATCO PHARMA With:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    



 

Today's Market

Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red(10:30 am)

Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.